UK start-up George Medicines has named Mark Mallon as its new chief executive, who will oversee the company as it tries to get its triple therapy for high blood pressure o
George Medicines has partnered with Medisante to provide technology for a study of an experimental triple therapy for hypertension that will allow most subjects to provide data from their o
